Members

Message

Hiroki R. Ueda, MD, PhD

Dear readers,
In the early 21st century, the environment surrounding the life sciences has changed dramatically, as represented by the decoding of genomes, the development of systems biology, and the rise of synthetic biology. Now, the life sciences surrounding humans are about to undergo a major change.
In recent years, it has become possible to capture human activities quantitatively, and human systems biology, which attempts to understand the principles behind human daily measurement data, has become a reality. For example, it is now possible to accurately measure human movement with accelerometers, analyze human sleep/wake patterns with high accuracy, and cluster them by phenotype. Now, it is becoming possible to analyze personal genomes easily and inexpensively. In addition, a method to produce many genetically modified mice without crossing has been established (next-generation genetics). As a result, it is now possible to verify the correlation between phenotypes and gene polymorphisms revealed by human phenotypic analysis and personal genome data using genetically modified mice, making it practical to discover causal relationships with high efficiency. In addition, it has become practical to genetically or chemically perturb (artificially disturb or change) important molecules to change the biological system to a desired state. Furthermore, advanced technological innovations from Japan are being developed as key technologies to tackle the remaining important issues in life science. For example, whole-organ profiling of cells and circuits in mammals, and the comprehensive analysis of all antigens recognized by antibodies in serum and life history analysis.
Through the ERATO-Ueda biological timing project, we hope to understand the behavior of the most important model organism, the human, at the individual level, and to understand "biological timing" information from the molecular level to the individual level of humans living in society. Using sleep-wake rhythms as a model system, we will examine the causal relationship between genes and phenotypes using human sleep measurement methods and next-generation mouse genetics. We also aim to understand and control sleep-wake rhythms at the molecular level, focusing on the regulation of protein phosphorylation. Through this project, we also hope to define what "healthy" sleep is, explore the causes of psychiatric and neurodegenerative diseases that are still difficult to treat.
We hope to contribute to the realization of such a systems-based medicine. However, a single researcher or a single laboratory is far from realizing true systems-based medicine. We sincerely ask for your cooperation and support.

Members

Head Quarters

Project Leader
Hiroki R. Ueda, MD, PhD Graduate School of Medicine, Deartment of Systems Pharmacology, The University of Tokyo, Professor
Laboratory for Synthetic Biology, RIKEN, BDR, Team Leader
Project Coordinator
Koji L. Ode, PhD Graduate School of Medicine, Deartment of Systems Pharmacology, The University of Tokyo, Lecturerer
Research Manager
Yoichi Minami, PhD Graduate School of Medicine, Deartment of Systems Pharmacology, The University of Tokyo, Project Associate Professor
Administrative Staff
Mari Tamura Graduate School of Medicine, Deartment of Systems Pharmacology, The University of Tokyo, Assistant
Naomi Iwasa Department of Systes Biology, Life Science Institute, Kurume University, Assistant

Human Sleep Group

Group Leader
Akifumi Kishi, PhD Graduate School of Medicine, Deartment of Systems Pharmacology, The University of Tokyo, Lecturer
Researcher
Katsuhiko Matsumoto, PhD Graduate School of Medicine, Deartment of Systems Pharmacology, The University of Tokyo, Guest Researcher
Yoichi Minami, PhD (Concurrent post) Graduate School of Medicine, Deartment of Systems Pharmacology, The University of Tokyo, Project Associate Professor
Technician
Sae Otsuki Graduate School of Medicine, Deartment of Systems Pharmacology, Assistant
Students
Three members (UT)

Animal Analysis Group

Group Leadert
Rikuhiro G. Yamada, PhD Department of Systes Biology, Life Science Institute, Kurume University, Associate Professor
Researcher
Hiroshi Fujishima, PhD Department of Systes Biology, Institute of Life Science, Kurume University, Assistant Professor
Maria Neus Ballester Roig, PhD Department of Systes Biology, Life Science Institute, Kurume University, Associate Professor
Masaki Nagao, PhD Graduate School of Medicine, Deartment of Systems Pharmacology, Assistant Professor
Technician
Risa Tsuneyoshi Department of Systes Biology, Institute of Life Science, Kurume University
Yuji Ochiai Department of Systes Biology, Institute of Life Science, Kurume University
Research Assistant
one member
Students
two members (Kurume) and six members (UT)

Molecular Control Group

Group Leader
Koji L Ode, PhD (Concurrent post) Graduate School of Medicine, Deartment of Systems Pharmacology, The University of Tokyo, Lecturerer
Researcher
Miki Kawano, PhD Graduate School of Medicine, Deartment of Systems Pharmacology, Researcher
Wen Zhiqing Graduate School of Medicine, Deartment of Systems Pharmacology, Researcher
Fumiya Tatsuki, PhD Graduate School of Medicine, Deartment of Systems Pharmacology, Researcher
Technician
Shiho Sato Graduate School of Medicine, Department o Systems Pharmacology, Technical Assistant
Kyoko Shimizu Graduate School of Medicine, Department o Systems Pharmacology, Technical Assistant
Ayako Shimokawa Graduate School of Medicine, Department o Systems Pharmacology, Technical Assistant
Students
eleven members (UT)

To top